当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Mark L. Nelson
Of all the antibiotic classes used in medicine, the Tetracycline’s (Tcs) stand out as extraordinary compounds and as bacteriostatic agents inhibiting protein synthesis in bacteria, the genesis of their success as medicinal and commercially valuable life-saving drugs. But they also possess unique anti-inflammatory activity in humans, where their activity is multifold having a long and rich history of affecting such pathways. Historically, the 1st generation fermentation Tcs affected the growth of α-proteobacteria rickettsias, known to cause infectious diseases such as spotted fevers and typhus, where chlortetracycline 1 was so effective against rickettsial disease it was approved for clinical use in 1947 even before the chemical structure was solved in the early 1950s.